LATEST NEWS
Immunome and Morphimmune Announce Definitive Merger Agreement… Learn More >
CORPORATE OVERVIEW
Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease.
LATEST NEWS
LATEST PRESENTATION
